Benefits of immunotherapy for advanced kidney cancer may persist after therapy cessation – Healio
|
Benefits of immunotherapy for advanced kidney cancer may persist after therapy cessation
Healio Patients with advanced kidney cancer who stop PD-1/PD-L1 immune checkpoint inhibitor therapy prematurely due to adverse events may be able to remain off additional systemic therapy for 6 months or more without disease progression, according to a small … |
